External beam radiotherapy boosts to reduce the impact caused by edema in prostate permanent seed implants

Physics in Medicine and Biology

Volumn 51, Issue 9, 2006, Pages 2267-2277

  Yue, Ning ^a   Mori, Jonathan ^b   Nath, Ravinder ^b   Heron, Dwight E ^a   Huq, M Saiful ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DRUG DOSAGE; IMPLANTS (SURGICAL); MATHEMATICAL MODELS; PATIENT TREATMENT; TUMORS;

EDEMA MAGNITUDES; LINEAR QUADRATIC MODEL; PROSTATE PERMANENT SEED IMPLANTS; TREATMENT EFFICACY;

RADIOTHERAPY;

IODINE 125; PALLADIUM 103;

ARTICLE; CALCULATION; CELL POPULATION; CELL REGENERATION; CELL SURVIVAL; DISEASE DURATION; DISEASE SEVERITY; EDEMA; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE PERMANENT SEED IMPLANT; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOISOTOPE THERAPY; STATISTICAL MODEL; SURGICAL TECHNIQUE; TREATMENT FAILURE; TUMOR CELL;

BRACHYTHERAPY; COMPUTER SIMULATION; DOSE FRACTIONATION; EDEMA; HUMANS; LINEAR MODELS; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL;

EID: 33646015647     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/51/9/011     Document Type: Article

References (24)

1. Blasko J C, Grimm P D, Sylvester J E, Badiozamani K R, Hoak D and Cavanagh W 2000 Palladium-103 brachytherapy for prostate carcinoma Int. J. Radiat. Oncol. Biol. Phys. 46 839-50
2. Brenner D J and Hall E J 1999 Fractionation and protraction for radiotherapy of prostate carcinoma Int. J. Radiat. Oncol. Biol. Phys. 43 1095-101
3. Chen Z, Yue N, Wang X, Roberts K B, Peschel R and Nath N 2000 Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution Int. J. Radiat. Oncol. Biol. Phys. 47 1405-19
4. Dale R G 1985 The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy Br. J. Radiol. 58 515-28
5. Dale R G 1989 Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model Br. J. Radiol. 62 241-4
6. Fowler J F, Chappell R and Ritter M A 2001 Is α/β for prostate really low? Int. J. Radiat. Oncol. Biol. Phys. 50 1021-31
7. 125I brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 51 31-40
8. Haustermans K and Fowler J F 2000 A comment on proliferation rates in human prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 48 303
9. Kal H B and Van Gellekom M P R 2003 How low is α/β ratio for prostate cancer? Int. J. Radiat. Oncol. Biol. Phys. 57 1122-30
10. 103Pd Int. J. Radiat. Oncol. Biol. Phys. 47 1165-67
11. Ling C C 1992 Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model Int. J. Radiat. Oncol. Biol. Phys. 23 81-7
12. Merrick G S, Butler W M, Dorsey A T and Walbert H L 1998 Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy Radiat. Oncol. Invest. 61998 182-90
13. Mitchell J B, Bedford J S and Bailey S M 1979 Dose-rate effects in mammalian cells in culture. III: comparison of cell killing and cell lines Radiat. Res. 79 537-51
14. Nath R, Anderson L L, Luxton G, Weaver K A, Williamson J F and Meigooni A S 1995 Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM radiation therapy committee task group no 43 Med. Phys. 22 209-34
15. Prestidge B R, Bice W S, Kiefer E J and Prete J J 1998 Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 40 1111-5
16. Rivard M J, Coursey B M, DeWerd L A, Hanson W F, Huq M S, Ibbott G S, Mitch M G, Nath R and Williamson J F 2004 Update of AAPM Task Group no 43 report: a revised AAPM protocol for brachytherapy dose calculations Med. Phys. 31 633-74
17. Wang J Z, Cuerrero M and Li X A 2003a How low is the α/β ratio for prostate cancer? Int. J. Radiat. Oncol. Biol. Phys. 55 194-203
18. Wang J Z, Li X A, Yu C X and DiBiase S J 2003b The low α/β ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us? Int. J. Radiat. Oncol. Biol. Phys. 57 1101-08
19. 103Pd prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition Int. J. Radiat. Oncol. Biol. Phys. 41 1069-77
20. Waterman F M, Yue N, Reisinger S, Dicker A and Corn B W 1997 Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study Int. J. Radiat. Oncol. Biol. Phys. 38 335-9
21. Williamson J F, Coursey B M, DeWerd L A, Hanson W F, Nath R and Ibbott G 1999 Guidance to users of Nycomed Amersham and Norht American Scientific, Inc., I-125 interstitial sources: dosimetry and calibration changes: recommendations of the American Associate of Physicists in Medicine Radiation Therapy Committee ad hoc subcommittee on low-energy seed dosimetry Med. Phys. 26 570-73
22. 103Pd interstitial source calibration and dosimetry: implications for dose specification and prescription Med. Phys. 27 643
23. 103Pd prostate implant Med. Phys. 26 763-67
24. 103Pd prostate permanent seed implants-a bio-mathematical model Phys. Med. Biol. 47 1185-204